Related Experiment Video
Updated: Jun 22, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Beyond Coronary Artery Disease: Assessing the Microcirculation
Sonal Pruthi1, Emaad Siddiqui1, Nathaniel R Smilowitz2
1Division of Cardiology, Department of Medicine, NYU Langone Health, 550 First Avenue, New York, NY 10016, USA.
Insights
Ischemic heart disease (IHD) affects millions, yet many patients lack blockages in major arteries. Microvascular angina due to coronary microvascular dysfunction (CMD) is a key cause, highlighting the need for better understanding and treatment of CMD.
Area of Science:
- Cardiology
- Vascular Biology
- Internal Medicine
Background:
- Ischemic heart disease (IHD) impacts over 20 million US adults.
- Atherosclerosis of epicardial coronary arteries is the traditional cause of IHD.
- Nearly half of patients with stable angina and IHD lack obstructive epicardial coronary artery disease.
Purpose of the Study:
- To explore the significance of ischemia with nonobstructive coronary arteries (INOCA).
- To highlight coronary microvascular dysfunction (CMD) as a common cause of INOCA and microvascular angina.
- To emphasize the potential of improved understanding and management of CMD for IHD patient outcomes.
Main Methods:
- Review of current literature on IHD, INOCA, and CMD.
- Analysis of diagnostic approaches for coronary microvascular dysfunction.
- Discussion of therapeutic strategies for patients with microvascular angina.
Main Results:
- Coronary microvascular dysfunction (CMD) is a frequent underlying cause of ischemia in patients without obstructive epicardial coronary artery disease.
- Microvascular angina is a clinical manifestation of CMD.
- Current diagnostic and treatment paradigms for CMD are evolving.
Conclusions:
- CMD is a critical, often overlooked, contributor to ischemic heart disease.
- Further research into the pathophysiology, diagnosis, and treatment of CMD is essential.
- Addressing CMD offers a promising avenue to improve clinical outcomes for a significant patient population experiencing IHD.
Abstract:
Ischemic heart disease (IHD) affects more than 20 million adults in the United States. Although classically attributed to atherosclerosis of the epicardial coronary arteries, nearly half of patients with stable angina and IHD who undergo invasive coronary angiography do not have obstructive epicardial coronary artery disease. Ischemia with nonobstructive coronary arteries is frequently caused by microvascular angina with underlying coronary microvascular dysfunction (CMD). Greater understanding the pathophysiology, diagnosis, and treatment of CMD holds promise to improve clinical outcomes of patients with ischemic heart disease.

